Wells Fargo Maintains Overweight on AptarGroup, Lowers Price Target to $125
Wells Fargo analyst Gabe Hajde maintains AptarGroup (NYSE:ATR) with a Overweight and lowers the price target from $150 to $125.
UBS Maintains Buy on ServiceNow, Lowers Price Target to $540
UBS analyst Karl Keirstead maintains ServiceNow (NYSE:NOW) with a Buy and lowers the price target from $570 to $540.
Truist Securities Maintains Buy on New Relic, Lowers Price Target to $80
Truist Securities analyst Joel Fishbein maintains New Relic (NYSE:NEWR) with a Buy and lowers the price target from $85 to $80.
Stifel Maintains Buy on Medtronic, Lowers Price Target to $105
Stifel analyst Rick Wise maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $125 to $105.
Guggenheim Maintains Buy on Merus, Raises Price Target to $46
Guggenheim analyst Charles Zhu maintains Merus (NASDAQ:MRUS) with a Buy and raises the price target from $44 to $46.
Guggenheim Maintains Buy on GoodRx Holdings, Lowers Price Target to $13
Guggenheim analyst Sandy Draper maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and lowers the price target from $17 to $13.
Stifel Maintains Buy on Edwards Lifesciences, Lowers Price Target to $115
Stifel analyst Rick Wise maintains Edwards Lifesciences (NYSE:EW) with a Buy and lowers the price target from $128 to $115.
Stifel Maintains Buy on Becton, Dickinson, Lowers Price Target to $280
Stifel analyst Rick Wise maintains Becton, Dickinson (NYSE:BDX) with a Buy and lowers the price target from $290 to $280.
Morgan Stanley Maintains Underweight on Restaurant Brands Intl, Lowers Price Target to $52
Morgan Stanley analyst John Glass maintains Restaurant Brands Intl (NYSE:QSR) with a Underweight and lowers the price target from $56 to $52.
Morgan Stanley Maintains Equal-Weight on Proterra, Lowers Price Target to $7
Morgan Stanley analyst Courtney Yakavonis maintains Proterra (NASDAQ:PTRA) with a Equal-Weight and lowers the price target from $9 to $7.